Maryna C Eichelberger

Title: Maryna C Eichelberger: Innovator in Influenza Research

Introduction

Maryna C Eichelberger is a notable inventor based in Silver Spring, MD (US). She has made significant contributions to the field of influenza research, particularly through her innovative work on antibodies that target the N1 subtype of the influenza virus. Her research has implications for both the detection and treatment of influenza infections.

Latest Patents

Maryna holds a patent for a "Potent anti-influenza A neuraminidase subtype N1 antibody." This patent describes isolated monoclonal antibodies and antigen binding fragments that specifically bind to neuraminidase (NA) of the N1 subtype influenza virus. These antibodies can be utilized for the detection of the N1 subtype influenza virus and for assessing the immunogenicity of vaccines. Furthermore, they can be employed in the treatment of subjects to prevent or ameliorate influenza infections.

Career Highlights

Maryna is affiliated with the United States of America, as represented by the Secretary, Department of Health and Human Services. Her work in this esteemed organization underscores her commitment to public health and innovation in medical research.

Collaborations

Throughout her career, Maryna has collaborated with notable colleagues, including Rebecca J Garten and James Stevens. These partnerships have likely enhanced her research and contributed to the advancement of influenza treatment methodologies.

Conclusion

Maryna C Eichelberger's contributions to influenza research through her patented innovations highlight her role as a key figure in the scientific community. Her work not only aids in the detection and treatment of influenza but also paves the way for future advancements in vaccine development.